XML 56 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2023
Summary of Percentages of Deferred Revenue by Year

    

Revenue

 

Year:

Recognition

 

2024

 

85

%

2025

 

13

%

2026

 

2

%

2027

 

%

2028

 

%

Total

 

100

%

Summary of Revenue Generated in Geographic Regions for Years Indicated

The following geographic data includes revenue generated from the Company’s third-party distributors. The Company’s revenue was generated in the following geographic regions and by product line for the periods indicated (in thousands):

Revenues by Geography

 

Year ended December 31, 

 

2023

2022

 

% of

% of

 

Amount

Revenues

Amount

Revenues

 

(in thousands, except percentages)

U.S.

    

$

69,336

    

97

%  

$

63,406

    

97

%

International

 

2,012

 

3

%  

 

1,800

 

3

%

Total revenues

$

71,348

 

100

%  

$

65,206

 

100

%

Revenues by Geography

 

Year ended December 31, 

 

2022

2021

 

% of

% of

 

    

Amount

    

Revenues

    

Amount

    

Revenues

 

(in thousands, except percentages)

United States

$

63,406

 

97

%  

$

53,447

 

97

%

International

 

1,800

 

3

%  

 

1,865

 

3

%

Total revenues

$

65,206

 

100

%  

$

55,312

 

100

%

U.S. Revenues by Product Category

 

Year ended December 31, 

 

2022

2021

 

    

    

% of

    

    

% of

 

Amount

Revenues

Amount

Revenues

 

 

(in thousands, except percentages)

NeuroStar Advanced Therapy System

$

16,575

 

26

%  

$

9,760

 

18

%

Treatment sessions

 

45,077

 

71

%  

 

41,933

 

78

%

Other

 

1,754

 

3

%  

 

1,754

 

4

%

Total U.S. revenues

$

63,406

 

100

%  

$

53,447

 

100

%

U.S.  
Summary of Revenue Generated in Product Category for Years Indicated

U.S. Revenues by Product Category

 

Year ended December 31, 

 

2023

2022

 

% of

% of

 

    

Amount

    

Revenues

    

Amount

    

Revenues

 

 

(in thousands, except percentages)

NeuroStar Advanced Therapy System

$

16,460

24

%  

$

16,575

26

%

Treatment sessions

 

50,896

 

73

%

 

45,077

 

71

%

Other

 

1,980

 

3

%

 

1,754

 

3

%

Total U.S. revenues

$

69,336

 

100

%

$

63,406

 

100

%

International  
Summary of Revenue Generated in Product Category for Years Indicated

International Revenues by Product Category

 

Year ended December 31, 

 

2023

2022

 

% of

% of

 

    

Amount

    

Revenues

    

Amount

    

Revenues

 

 

(in thousands, except percentages)

NeuroStar Advanced Therapy System

$

629

 

31

%  

$

811

 

45

%

Treatment sessions

 

754

 

38

%  

 

354

 

20

%

Other

 

629

 

31

%  

 

635

 

35

%

Total International revenues

$

2,012

 

100

%  

$

1,800

 

100

%

International Revenues by Product Category

 

Year ended December 31, 

 

2022

2021

 

% of

% of

 

    

Amount

    

Revenues

    

Amount

    

Revenues

 

(in thousands, except percentages)

 

NeuroStar Advanced Therapy System

$

811

    

45

%  

$

1,108

    

59

%

Treatment sessions

 

354

 

20

%  

 

264

 

14

%

Other

 

635

 

35

%  

 

493

 

27

%

Total International revenues

$

1,800

 

100

%  

$

1,865

 

100

%